Shrikrupa Sales

Taficita (emtricitabine and tenofovir alafenamide) is an antiviral medication used in combination with other medicines to treat human immunodeficiency virus (HIV) infection. It is also used as pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection. This medication works by preventing the HIV virus from multiplying, which helps to control the infection and improve the function of the immune system. It does not cure HIV or AIDS, but it can help slow the progression of the disease and improve a person's quality of life.

 

Tafnat (tenofovir alafenamide) 25mg tablets are an antiviral medication used primarily to treat chronic hepatitis B virus (HBV) infection in adults and adolescents aged 12 and older with compensated liver disease. It is also used as part of a combination therapy for the treatment of HIV-1 infection. This medication works by inhibiting the multiplication of the virus, which helps to reduce the viral load in the body and clear the infection, thereby improving liver health and a person's quality of life.

 

Sovaldi 400 mg tablets contain the active ingredient sofosbuvir, a direct-acting antiviral medication used in combination with other drugs to treat chronic hepatitis C virus (HCV) infection. Sofosbuvir works by inhibiting a specific protein that the virus needs to multiply, effectively reducing the amount of HCV in the body and helping to clear the infection. Sovaldi is not used as a monotherapy; it must be combined with other medicines, such as ribavirin or peginterferon alfa, for an effective treatment regimen

Sofosbuvir 400 mg tablets, sold under the brand name Sovaldi, are an antiviral medication used in combination with other drugs to treat chronic hepatitis C virus (HCV) infection. It is a direct-acting antiviral that works by inhibiting a protein (NS5B polymerase) that the virus needs to replicate, thereby reducing the viral load in the body and helping to clear the infection over time. Sofosbuvir is not used alone and is always part of a combination therapy, often with other drugs like ribavirin, peginterferon alfa, or other direct-acting antivirals like velpatasvir.

 

Novisof 400 mg tablets contain the active ingredient sofosbuvir, a direct-acting antiviral medication used in combination with other drugs to treat chronic hepatitis C virus (HCV) infection in adults and adolescents aged 12 and older. It works by inhibiting the NS5B polymerase enzyme, which is crucial for the replication of the hepatitis C virus. By blocking this enzyme, Novisof helps to lower the viral load, improve liver function, and prevent further liver damage. It is important to note that this medication is not used as a standalone treatment and must be taken with other antiviral medicines to be effective.

Sofosbuvir 400 mg tablets, widely known by the brand name Sovaldi, are an antiviral medication used as a part of a combination therapy to treat chronic hepatitis C virus (HCV) infection. Sofosbuvir is a direct-acting antiviral that works by inhibiting the NS5B polymerase enzyme, which the virus needs to multiply. This action helps to reduce the viral load in the body, leading to the clearance of the infection and improvement of liver health. It is never used as a standalone treatment for hepatitis C and is always prescribed with other antiviral drugs like ribavirin, peginterferon alfa, or other direct-acting antivirals

Hepcinat Sofosbuvir 400 mg tablet is a direct-acting antiviral medication used in combination with other drugs to treat chronic hepatitis C virus (HCV) infection. It works by inhibiting a specific protein that the virus needs to replicate, thereby reducing the amount of HCV in the body and helping to clear the infection. Hepcinat is not intended to be used as a standalone treatment and must be prescribed as part of a combination regimen with other antiviral medications.

 

 

Teevir is a combination antiviral medicine used to treat HIV-1 infection. It contains three active ingredients: Emtricitabine (200 mg), Tenofovir disoproxil fumarate (300 mg), and Efavirenz (600 mg). This fixed-dose combination therapy works by preventing the HIV virus from multiplying in the body, which helps to control the infection, improve immune system function, and reduce the risk of HIV-related complications. It is important to note that Teevir is not a cure for HIV or AIDS.

 

 

Ricovir EM is a combination antiviral medicine that contains emtricitabine (200 mg) and tenofovir disoproxil fumarate (300 mg). This medication is primarily used to treat HIV-1 infection in adults and adolescents and is also used as a pre-exposure prophylaxis (PrEP) to help prevent HIV-1 infection in uninfected individuals who are at high risk. It belongs to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs), which work by preventing the HIV virus from multiplying in the body.

 

Axentri 150 mg tablet contains the active ingredient maraviroc, an antiviral medication used to treat human immunodeficiency virus (HIV) infection. It belongs to a class of drugs known as CCR5 antagonists, or entry inhibitors. Unlike other HIV medications that prevent the virus from multiplying after it has entered a cell, maraviroc works by preventing the HIV virus from entering human cells in the first place. It specifically binds to a protein called CCR5 on the surface of certain immune cells, which is a receptor that some types of HIV use to gain entry. This action effectively blocks the virus from infecting the cells.

Viropil Tablet is a combination of three antiretroviral medicines used for the treatment of Human Immunodeficiency Virus (HIV) type 1 infection. The tablet contains dolutegravir (50 mg), lamivudine (300 mg), and tenofovir disoproxil fumarate (300 mg). This fixed-dose combination therapy works by inhibiting the action of specific enzymes that the HIV virus needs to multiply and replicate, thereby reducing the viral load in the body. This helps to improve the immune system's function, fight off infections, and reduce the risk of HIV-related complications, ultimately improving the patient's quality of life.

 

Tenof-Em is a combination of two antiviral medications, emtricitabine (200 mg) and tenofovir disoproxil fumarate (300 mg). This medication is a nucleoside reverse transcriptase inhibitor (NRTI) and is used for two main purposes: to treat HIV-1 infection and as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in high-risk individuals

Tavin-Em is a combination antiviral medication containing emtricitabine (200 mg) and tenofovir disoproxil fumarate (300 mg). This drug belongs to a class of medicines called nucleoside reverse transcriptase inhibitors (NRTIs). It is used for two main purposes: to treat human immunodeficiency virus (HIV) type 1 infection in adults and adolescents, and as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in uninfected individuals who are at high risk.

 

Velpanat tablets are a combination of two antiviral medicines, sofosbuvir (400 mg) and velpatasvir (100 mg). This medication is used to treat chronic hepatitis C virus (HCV) infection in adults and adolescents, and it is effective against all genotypes of the virus. It works by inhibiting key proteins that the virus needs to replicate, thereby reducing the amount of HCV in the body and helping to clear the infection. In some cases, particularly for patients with decompensated cirrhosis, it may be used in combination with another medication called ribavirin.

Inbec is a fixed-dose combination tablet containing three active ingredients: Abacavir (600 mg), Dolutegravir (50 mg), and Lamivudine (300 mg). This medication is an antiretroviral drug used to treat human immunodeficiency virus (HIV) type 1 infection in adults and adolescents weighing at least 40 kg. It works by combining the actions of two different classes of drugs: nucleoside reverse transcriptase inhibitors (NRTIs), which are Abacavir and Lamivudine, and an integrase inhibitor, which is Dolutegravir. Together, they prevent the HIV virus from multiplying, which helps to reduce the viral load in the body and strengthens the immune system to fight off infections.

 

Ledifos tablets are a combination of two antiviral medicines, ledipasvir (90 mg) and sofosbuvir (400 mg). This medication is used for the treatment of chronic hepatitis C virus (HCV) infection in adults and adolescents, and is effective against certain genotypes of the virus, particularly genotype 1, which is the most common. It works by inhibiting specific proteins and enzymes that the hepatitis C virus needs to replicate, thereby stopping the virus from multiplying and helping to clear the infection.

 

Entecavir 0.5 mg tablets are an antiviral medication used to treat chronic (long-term) hepatitis B virus (HBV) infection. This medicine is a nucleoside analog that works by preventing the virus from multiplying, which helps to reduce the amount of HBV in the body and lessen the risk of liver damage, cirrhosis, and liver cancer. It is not a cure for hepatitis B and does not prevent the spread of the virus to others.

 

Entehep Entecavir 0.5 mg tablets contain the active ingredient entecavir, an antiviral medication used to treat chronic hepatitis B virus (HBV) infection. This medicine is a nucleoside analogue that works by inhibiting a key enzyme, viral DNA polymerase, which the virus needs to replicate. By preventing the virus from multiplying, Entehep reduces the amount of HBV in the body, helping to decrease liver damage, reduce inflammation, and improve liver function. It is important to note that this medication does not cure hepatitis B and does not prevent the spread of the virus to others.

 

 

Ledviclear tablets are a combination of two antiviral medicines: ledipasvir (90 mg) and sofosbuvir (400 mg). This medication is prescribed for the treatment of chronic (long-term) hepatitis C virus (HCV) infection in adults and adolescents, and is effective against certain genotypes of the virus, including genotypes 1, 4, 5, and 6. It works by inhibiting key proteins and enzymes that the virus needs to replicate, thereby reducing the amount of HCV in the body and helping to clear the infection.

Vonavir is a combination antiviral medicine that contains three active ingredients: Efavirenz (600 mg), Emtricitabine (200 mg), and Tenofovir disoproxil fumarate (300 mg). This fixed-dose combination therapy is used to treat human immunodeficiency virus (HIV) type 1 infection in adults and adolescents. It works by combining the actions of two different classes of drugs to prevent the HIV virus from multiplying in the body, which helps to reduce the viral load and strengthen the immune system

Dacihep 60 mg tablets contain the active ingredient daclatasvir, which is an antiviral medicine used to treat chronic hepatitis C virus (HCV) infection. It belongs to a class of drugs known as NS5A inhibitors and works by blocking a key protein that the hepatitis C virus needs to replicate, thereby stopping the virus from multiplying. It is important to note that daclatasvir is not used as a monotherapy and is always prescribed in combination with other antiviral medications, most commonly sofosbuvir, with or without ribavirin. This combination therapy is highly effective in clearing the virus from the body and is used for specific genotypes of HCV, such as genotype 1 or 3.

 

 

Emletra Tablet is a combination of Ritonavir and Lopinavir, two antiretroviral medications used in the treatment of HIV infection. Ritonavir enhances the effectiveness of Lopinavir by increasing its concentration, helping to control viral load and slow the progression of the disease when used as part of combination antiretroviral therapy

Viraday, manufactured by Cipla, is a combination antiretroviral medicine used to treat human immunodeficiency virus (HIV) type 1 infection. It contains three active ingredients: Efavirenz (600 mg), Emtricitabine (200 mg), and Tenofovir disoproxil fumarate (300 mg). This medication is a generic version of the brand-name drug Atripla, which has been discontinued by its manufacturer in some regions but has a widely available generic version

Ribasure 200 mg capsules contain the active ingredient ribavirin, an antiviral medicine used to treat chronic (long-term) hepatitis C virus (HCV) infection. It is not used alone and is always prescribed in combination with other antiviral medications, such as pegylated interferon or direct-acting antivirals. Ribavirin works by preventing the virus from multiplying, which helps to reduce the viral load in the body and clear the infection.

 

 

Daclahep 60mg tablets contain the active ingredient daclatasvir, which is an antiviral medicine used for the treatment of chronic hepatitis C virus (HCV) infection. Daclatasvir is a Hepatitis C virus (HCV) NS5A inhibitor. It works by blocking a key protein that the virus needs to replicate, thereby stopping the virus from multiplying and reducing the viral load in the body. This medication is not used as a standalone treatment; it is always prescribed in combination with other antiviral medicines, most commonly with sofosbuvir, with or without ribavirin, to achieve a high rate of cure.

 

Adefovir Dipivoxil 10mg tablets are an antiviral medication indicated for the treatment of chronic hepatitis B in adults and adolescents aged 12 years and older. As a nucleotide analog reverse transcriptase inhibitor (ntRTI), adefovir dipivoxil works by inhibiting the replication of the hepatitis B virus (HBV), thereby reducing viral load and liver inflammation. It is typically administered orally at a dosage of 10 mg once daily, with or without food. While effective in managing chronic HBV infection, adefovir dipivoxil is not considered a first-line therapy due to the potential development of viral resistance over time. Regular monitoring of liver and kidney function is recommended during treatment.

Dinex EC 250mg capsule contains the active ingredient didanosine, which is an antiviral medicine used to treat human immunodeficiency virus (HIV) infection. It belongs to a class of drugs called nucleoside reverse transcriptase inhibitors (NRTIs). This medication works by preventing the HIV virus from multiplying in the body, which helps to control the infection and improve the function of the immune system. Dinex EC is not a cure for HIV, but it helps to slow the progression of the disease and can be used in combination with other antiretroviral medicines.

 

Indivan 400 mg capsules contain the active ingredient indinavir, which is an antiviral medicine used to treat human immunodeficiency virus (HIV) infection. It belongs to a class of drugs called protease inhibitors. Indinavir works by blocking a key enzyme, protease, that is required by HIV-infected cells to produce new viruses. By inhibiting this enzyme, it prevents the virus from multiplying, which helps to reduce the viral load in the body and strengthens the immune system. Indivan is not a cure for HIV or AIDS and is always used in combination with other antiretroviral medicines.

Daruvir 600 R Tablet is a combination antiretroviral medicine used to treat human immunodeficiency virus (HIV) infection. It contains two active ingredients: Darunavir (600 mg) and Ritonavir (100 mg). This medicine works by interfering with an enzyme called protease, which is crucial for the HIV virus to replicate and create new viruses. By blocking this process, it reduces the amount of HIV in the body and helps to strengthen the immune system, thereby reducing the risk of developing HIV-related illnesses such as AIDS. It's important to understand that this medication does not cure HIV but helps to manage the infection and improve a person's lifespan.

 

 

Atazor 200 mg tablets contain the active ingredient atazanavir, which is an antiviral medicine used to treat human immunodeficiency virus (HIV) infection. It belongs to a class of drugs called protease inhibitors. Atazanavir works by blocking a key enzyme, protease, that is essential for HIV-infected cells to produce new viruses. This action prevents the virus from multiplying, which helps to reduce the viral load in the body and strengthens the immune system, thereby reducing the risk of developing HIV-related illnesses.

 

Abamune-L 600 mg tablets contain a combination of two antiviral medicines: abacavir (600 mg) and lamivudine (300 mg). This medication is used as part of a combination therapy to treat human immunodeficiency virus (HIV) type 1 infection in adults and adolescents. It belongs to a class of drugs called nucleoside reverse transcriptase inhibitors (NRTIs). These drugs work by interfering with enzymes that the HIV virus needs to multiply, thereby helping to reduce the viral load in the body and strengthen the immune system.

Stavir 40 mg capsules contain the active ingredient stavudine, which is an antiviral medicine used to treat human immunodeficiency virus (HIV) infection. It belongs to a class of drugs called nucleoside reverse transcriptase inhibitors (NRTIs). Stavudine works by preventing the HIV virus from multiplying in the body, which helps to reduce the viral load and strengthen the immune system. This medication is not a cure for HIV or AIDS and is typically prescribed in combination with other antiretroviral medicines.

 

Triomune is a combination antiretroviral medicine used to treat human immunodeficiency virus (HIV) infection. It contains three active ingredients: lamivudine (150 mg), stavudine (30 mg or 40 mg, though often a fixed-dose combination with 30 mg is used), and nevirapine (200 mg). This fixed-dose combination therapy works by preventing the HIV virus from multiplying in the body, which helps to reduce the viral load and strengthen the immune system.

 

Lopimune tablets are a combination of two antiviral medicines: lopinavir and ritonavir. This medication is used to treat human immunodeficiency virus (HIV) infection. Both lopinavir and ritonavir belong to a class of drugs called protease inhibitors. Lopinavir is the primary active drug that works by blocking the protease enzyme, which the HIV virus needs to create new, infectious virus particles. Ritonavir is included to "boost" the effect of lopinavir by inhibiting its breakdown in the body, allowing lopinavir to remain in the system for longer at higher concentrations.

 

Nevimune 200 mg tablets contain the active ingredient nevirapine, which is an antiviral medicine used to treat human immunodeficiency virus (HIV) infection. It belongs to a class of drugs called non-nucleoside reverse transcriptase inhibitors (NNRTIs). Nevirapine works by blocking a key enzyme, reverse transcriptase, that the HIV virus needs to multiply and replicate in human cells. By inhibiting this process, it helps to reduce the viral load in the body and strengthens the immune system to fight off infections.

Solocure V 400mg tablets are a combination of two antiviral medicines, Sofosbuvir (400mg) and Velpatasvir (100mg), and are used for the treatment of chronic Hepatitis C virus (HCV) infection. This medication works by preventing the virus from multiplying, thereby reducing the amount of HCV in the body and helping to clear the infection. It is highly effective and can lead to a cure in a high percentage of patients.

 

 

Hepcinat Plus 60mg/400mg Tablet is a combination medicine used in the treatment of chronic hepatitis C virus (HCV) infection. It works by reducing the number of hepatitis C viruses in the body and removing the virus from the blood over a period of time.
Hepcinat Plus 60mg/400mg Tablet should be taken with or without food at a fixed time each day to maintain consistent levels of medicine in the blood. In case you miss a dose of this medicine, take it as soon as you remember. Never skip any doses and finish the full course of treatment even if you feel better. It is important not to stop taking this medicine suddenly as it may worsen your symptoms.
Hepcinat Plus 60mg/400mg Tablet may cause side effects like nausea, headache, and fatigue. Inform your doctor if these side effects do not resolve or persist for a longer duration. Please consult your doctor if you are pregnant, planning to conceive or breastfeeding.Uses of Hepcinat Plus Tablet

Twinaqt is a combination of two antiretroviral medicines, dolutegravir (50 mg) and lamivudine (300 mg), used to treat human immunodeficiency virus (HIV) type 1 infection in adults and adolescents weighing at least 40 kg. It combines two different classes of drugs to prevent the HIV virus from multiplying in the body. Dolutegravir is an integrase inhibitor that blocks the viral DNA from integrating into the host cell's DNA, while lamivudine is a nucleoside reverse transcriptase inhibitor that disrupts an enzyme essential for viral replication. This dual action helps to reduce the viral load and strengthen the immune system

Lazid N Tablet is a combination of three antiretroviral medicines used for the treatment of Human Immunodeficiency Virus (HIV) infection. The tablet contains lamivudine (150 mg), zidovudine (300 mg), and nevirapine (200 mg). This fixed-dose combination therapy works by preventing the HIV virus from multiplying in the body, which helps to reduce the viral load and strengthen the immune system to fight off infections. It is important to note that Lazid N is not a cure for HIV or AIDS and does not prevent the transmission of the virus to others.

 

Viracept (mesilato de nelfinavir) is an antiviral medication used in the treatment of human immunodeficiency virus (HIV) infection. It belongs to a class of drugs known as protease inhibitors. Nelfinavir works by blocking a key enzyme, HIV protease, that the virus needs to mature and create new, infectious virus particles. By inhibiting this enzyme, it prevents the virus from multiplying, which helps to reduce the viral load in the body and strengthen the immune system.